1994 in pharma — approvals, patent cliffs, Phase 3 readouts
FDA / EMA / MHRA approvals (40)
- — Flonase · GSK (GlaxoSmithKline) · United States · Oncology
- — Cozaar · Merck & Co. · Metabolic
- — VALACYCLOVIR · Metabolic
- — Coreg · Waylis · Cardiovascular
- — Flolan · AstraZeneca · Cardiovascular
- — Nimbex · AbbVie · Neuroscience
- — Revex · Hikma · Neuroscience
- — Corvert · Pfizer · Cardiovascular
- — Valtrex · GSK · Immunology
- — Ethyol · Cosette · Oncology
- — Onon · Immunology
- — Rilutek · Covis · Neuroscience
- — Epivir · GSK · Immunology
- — Dirythromycin · Infectious Disease
- — SEVOFLURANE
- — Cellcept · Roche Palo · Oncology
- — Azelex · Leo Pharma As · Dermatology
- — Casodex · ANI Pharmaceuticals · Oncology
- — Precose · Bayer · Metabolic
- — Sular · Azurity · Cardiovascular
- — Zinecard · Pfizer · Oncology
- — Amaryl · Sanofi · Metabolic
- — ANASTROZOLE
- — MOEXIPRIL
- — CETIRIZINE HYDROCHLORIDE
- — BICALUTAMIDE
- — CISATRACURIUM BESYLATE
- — Femstat 3 · Bayer · Infectious Disease
- — METFORMIN HYDROCHLORIDE
- — METFORMIN
- — Photofrin · Concordia Labs Inc · Oncology
- — CEFTIBUTEN
- — FOLLITROPIN ALFA
- — DOCETAXEL
- — PORFIMER SODIUM
- — Cedax · Burke Therap · Infectious Disease
- — Ultravist 370 · Bayer · Other
- — Ioxitol · Guerbet · Other
- — Nimbex · AbbVie · Neuroscience
- — Fosamax · Merck And Co Inc · Bone